164 related articles for article (PubMed ID: 34102825)
1. [Analysis of bloodstream infections in children with acute myeloid leukemia during induction chemotherapies].
Ren YY; Ruan M; Chang LX; Liu TF; Liu F; Zhang L; Chen YM; Guo Y; Yang WY; Zhu XF
Zhonghua Er Ke Za Zhi; 2021 Jun; 59(6):501-505. PubMed ID: 34102825
[No Abstract] [Full Text] [Related]
2. Bloodstream infections in pediatric patients with acute leukemia: Emphasis on gram-negative bacteria infections.
Kuo FC; Wang SM; Shen CF; Ma YJ; Ho TS; Chen JS; Cheng CN; Liu CC
J Microbiol Immunol Infect; 2017 Aug; 50(4):507-513. PubMed ID: 26442676
[TBL] [Abstract][Full Text] [Related]
3. [Pathogenic characteristics and influence factors of bloodstream infection-induced severe sepsis in pediatric intensive care unit].
Dou JY; Zhou YP; Cui Y; Sun T; Shi JY; Xiong X; Zhang YC
Zhonghua Yi Xue Za Zhi; 2024 Jan; 104(3):198-204. PubMed ID: 38220445
[No Abstract] [Full Text] [Related]
4. [Single Center Clinical Analysis of Bloodstream Infection Pathogens in Children with Acute Leukemia].
Chu JH; Liu KK; Wang NL; Tu SJ; Cai HJ; Wu ZY; Yang LH; Xie ZW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):357-360. PubMed ID: 35395963
[TBL] [Abstract][Full Text] [Related]
5. Trends in bacterial bloodstream infections and resistance in immuno-compromised patients with febrile neutropenia: a retrospective analysis.
Raad C; Behdenna A; Fuhrmann C; Conter C; Cuzzubbo D; Rasigade JP; Bertrand Y; Domenech C
Eur J Pediatr; 2021 Sep; 180(9):2921-2930. PubMed ID: 33835249
[TBL] [Abstract][Full Text] [Related]
6. Bloodstream infections in oncology patients at Red Cross War Memorial Children's Hospital, Cape Town, from 2012 to 2014.
Mvalo T; Eley B; Bamford C; Stanley C; Chagomerana M; Hendricks M; Van Eyssen A; Davidson A
Int J Infect Dis; 2018 Dec; 77():40-47. PubMed ID: 30244075
[TBL] [Abstract][Full Text] [Related]
7. Blood stream infections during chemotherapy-induced neutropenia in adult patients with acute myeloid leukemia: treatment cycle matters.
Syrjälä H; Ohtonen P; Kinnunen U; Räty R; Elonen E; Nousiainen T; Jantunen E; Remes K; Itälä-Remes M; Silvennoinen R; Koistinen P;
Eur J Clin Microbiol Infect Dis; 2010 Oct; 29(10):1211-8. PubMed ID: 20556469
[TBL] [Abstract][Full Text] [Related]
8. Multidrug-resistant Gram-negative Bacterial Bloodstream Infections in Children's Hospitals in Japan, 2010-2017.
Aizawa Y; Shoji T; Ito K; Kasai M; Sakurai H; Toyofuku E; Minami K; Hoshino T; Horikoshi Y
Pediatr Infect Dis J; 2019 Jul; 38(7):653-659. PubMed ID: 30672891
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of prognostic risk factors of bloodstream infection in intensive care unit patients].
Huang Y; Gong C; Fu J; Liu X; Bi H; Wang H; Liu Y; Tang Y; Wang D
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1440-1444. PubMed ID: 33541494
[TBL] [Abstract][Full Text] [Related]
10. Enteric gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit.
Cordero L; Rau R; Taylor D; Ayers LW
Am J Infect Control; 2004 Jun; 32(4):189-95. PubMed ID: 15175611
[TBL] [Abstract][Full Text] [Related]
11. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
[TBL] [Abstract][Full Text] [Related]
12. Bloodstream gram-negative bacterial infections in adult patients with leukemia: A retrospective review of medical records in a tertiary care hospital in Western Saudi Arabia.
Merdad R; Alyami A; Basalim A; Alzahrani A; Aldainiy A; Awadh A; Ghulam E; Farahat F
J Infect Public Health; 2023 Oct; 16(10):1525-1530. PubMed ID: 37557008
[TBL] [Abstract][Full Text] [Related]
13. Influence of chemotherapy courses on the rate of bloodstream infections during neutropenia in adult acute myeloid leukaemia.
Kinnunen U; Koistinen P; Ohtonen P; Koskela M; Syrjälä H
Scand J Infect Dis; 2008; 40(8):642-7. PubMed ID: 18979602
[TBL] [Abstract][Full Text] [Related]
14. [IDA-FLAG (idarubicin, fludarabine, high dosage cytarabine and G-CSF)--an effective therapy regimen in treatment of recurrent acute myelocytic leukemia in children and adolescents. Initial results of a pilot study].
Fleischhack G; Graf N; Hasan C; Ackermann M; Breu H; Zernikow B; Bode U
Klin Padiatr; 1996; 208(4):229-35. PubMed ID: 8926688
[TBL] [Abstract][Full Text] [Related]
15. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
Creutzig U; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Lehrnbecher T
J Clin Oncol; 2004 Nov; 22(21):4384-93. PubMed ID: 15514380
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics and risk factors of blood stream infections after orthopedic surgery].
Tang Y; Liu Z; Yang P; Song J; Chen Y; Zhang Y; Wang K
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2021 May; 35(5):593-600. PubMed ID: 33998213
[TBL] [Abstract][Full Text] [Related]
17. [Mitoxantrone-cytarabine-etoposide induction therapy in children with acute myeloid leukemia: a single-center study of complications and clinical outcomes].
Chen XY; Ruan M; Zhao BB; Wang SC; Chen XJ; Zhang L; Guo Y; Yang WY; Zou Y; Chen YM; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jan; 21(1):24-28. PubMed ID: 30675859
[TBL] [Abstract][Full Text] [Related]
18. Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor.
Mikulska M; Raiola AM; Galaverna F; Balletto E; Borghesi ML; Varaldo R; Gualandi F; Giannoni L; Pastori G; Giacobbe DR; Signori A; Del Bono V; Viscoli C; Bacigalupo A; Angelucci E
Biol Blood Marrow Transplant; 2018 Jan; 24(1):109-118. PubMed ID: 28860000
[TBL] [Abstract][Full Text] [Related]
19. Bloodstream infections in pediatric patients.
Babay HA; Twum-Danso K; Kambal AM; Al-Otaibi FE
Saudi Med J; 2005 Oct; 26(10):1555-61. PubMed ID: 16228055
[TBL] [Abstract][Full Text] [Related]
20. Incidence, risk factors, and outcome of blood stream infections during the first 100 days post-pediatric allogeneic and autologous hematopoietic stem cell transplantations.
Youssef A; Hafez H; Madney Y; Elanany M; Hassanain O; Lehmann LE; El Haddad A
Pediatr Transplant; 2020 Feb; 24(1):e13610. PubMed ID: 31682054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
